ABC analysis: a tool of effectively controlling pharmaceutical expenditure in Greek NHS hospitals

被引:5
|
作者
Kastanioti, Catherine [1 ,2 ]
Mavridoglou, George [1 ,2 ]
Karanikas, Haralampos [3 ]
Polyzos, Nikolaos [4 ]
机构
[1] Technol Educ Inst Peloponnese, Dept Hlth, Antikalamos Messinias 24100, Kalamata, Greece
[2] Technol Educ Inst Peloponnese, Welf Unit Management, Antikalamos Messinias 24100, Kalamata, Greece
[3] Technol Educ Inst Sterea Ellada, Dept Informat & Comp Technol, Lamia, Greece
[4] Democritus Univ Thrace, Dept Social Management, Komotini, Greece
关键词
ABC analysis; expenditure; Greek NHS Hospitals; pharmaceuticals;
D O I
10.1111/jphs.12137
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectivesThe technical cost analysis, in order to highlight expensive medicines, is an important factor in the administration of health units. The purpose of the study is to analyse the annual pharmaceutical expenditures in NHS hospitals and to investigate the therapeutic categories requiring greater supervisory, for years 2013-2014. MethodsThe study was conducted at 19 public hospitals (9900 beds) and the data of annual consumption and expenditure incurred on each medicine using ATC classification were collected via observe.net web system and then arranged in descending order based on the Pareto principle. Key findingsABC analysis revealed that 21% (J, B, L) items (at ATC-1 level) represented class A amounting for nearly 80% (91 150 641 euros) of annual NHS pharmaceutical expenditure. Furthermore, approximately 9% (30) items (at ATC-4 level) represents class A, accounting for nearly 70% of annual pharmaceutical expenditures for year 2013, and 11% of items are responsible for nearly 80% of cumulative ADE for year 2014. ConclusionsThe inventory control is an effective measure for cost management of pharmaceutical expenditure by identifying the drugs requiring stringent control for rational use of funds in public hospitals.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 7 条
  • [1] SAVINGS ON PHARMACEUTICAL EXPENDITURE IN GREEK NHS HOSPITALS UNDER THE SHADOW OF THE INTERNATIONAL MONETARY FUND (IMF)
    Karapanos, N.
    Androutsou, L.
    Dede, Z.
    Geitona, M.
    VALUE IN HEALTH, 2011, 14 (07) : A344 - A344
  • [2] HOW PHARMACEUTICAL COST INDICATORS ARE AFFECTED WHEN ADJUSTED TO HOSPITALS' CLINICAL WORKLOAD: DATA ANALYSIS FOR GREEK NHS HOSPITALS
    Christodoulakis, A.
    Karanikas, H.
    Billiris, A.
    Thireos, E.
    VALUE IN HEALTH, 2015, 18 (07) : A533 - A533
  • [3] The contribution of generic substitution to rationalizing pharmaceutical expenditure in Greek public hospitals under recent economic crisis
    Kontodimopoulos, Nick
    Kastanioti, Catherine
    Thireos, Eleftherios
    Karanikas, Haralampos
    Polyzos, Nikolaos
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2013, 4 (04) : 211 - 216
  • [4] Employing post-DEA Cross-evaluation and Cluster Analysis in a Sample of Greek NHS Hospitals
    Flokou, Angeliki
    Kontodimopoulos, Nick
    Niakas, Dimitris
    JOURNAL OF MEDICAL SYSTEMS, 2011, 35 (05) : 1001 - 1014
  • [5] Employing post-DEA Cross-evaluation and Cluster Analysis in a Sample of Greek NHS Hospitals
    Angeliki Flokou
    Nick Kontodimopoulos
    Dimitris Niakas
    Journal of Medical Systems, 2011, 35 : 1001 - 1014
  • [6] Impact of Medical-Pharmaceutical Separation Reform on Hospitalization Expenditure in Tertiary Public Hospitals: Difference-in-Difference Analysis Based on Panel Data from Beijing
    Wang, Wenjuan
    Liang, Juanjuan
    Fan, Rong
    Cai, Yuanqing
    Yin, Baisong
    Hu, Yangyi
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2024, 17 : 1263 - 1276
  • [7] COST IMPACT ANALYSIS OF USING IMPROVE® TOOL FOR VENOUS THROMBOEMBOLISM RISK ASSESSMENT IN MEDICAL PATIENTS ADMITTED TO THE UK NHS HOSPITALS TO INFORM NICE CLINICAL GUIDELINE RECOMMENDATION
    Mather, I
    Dawoud, D.
    Donald, I
    Chandra, D.
    Sharpin, C.
    Stansby, G.
    Barry, P.
    VALUE IN HEALTH, 2018, 21 : S99 - S99